1.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

2.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

3.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

4.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

5.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

6.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

7.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

8.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

9.

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

1.

Results of Belgian patients with RPE65-related inherited retinal dystrophy 6 months after treatment with voretigene neparvovec

1.

sj-pdf-1-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

2.

sj-pdf-1-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

3.

sj-pdf-1-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

1.

sj-pdf-2-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

2.

sj-pdf-2-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

3.

sj-pdf-2-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

1.

sj-pdf-3-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

2.

sj-pdf-3-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

3.

sj-pdf-3-sci-10.1177_00368504211029775 – Supplemental material for Euthanasia in adults with psychiatric conditions: A descriptive study of the experiences of Belgian psychiatrists...

1.

Hoe omgaan met een euthanasieverzoek in psychiatrie binnen het huidig wettelijk kader? Adviestekst van de Vlaamse Vereniging voor Psychiatrie (VVP) over te hanteren zorgvuldigheids...

2.

Hoe omgaan met een euthanasieverzoek in psychiatrie binnen het huidig wettelijk kader? Adviestekst van de Vlaamse Vereniging voor Psychiatrie (VVP) over te hanteren zorgvuldigheids...

1.

The gene encoding nicastrin, a major g-secretase component, modifies risk for familial early-onset Alzheimer's disease in a Dutch population-based sample

2.

The gene encoding nicastrin, a major g-secretase component, modifies risk for familial early-onset Alzheimer's disease in a Dutch population-based sample

1.

The Gene Encoding Nicastrin, a Major γ-Secretase Component, Modifies Risk for Familial Early-Onset Alzheimer Disease in a Dutch Population-Based Sample

2.

The Gene Encoding Nicastrin, a Major γ-Secretase Component, Modifies Risk for Familial Early-Onset Alzheimer Disease in a Dutch Population-Based Sample

1.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

2.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

3.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

4.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

5.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

6.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

7.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

8.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

9.

Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking.

1.

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients

2.

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients

3.

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients

4.

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients